- Home
- CRL vs RITM Comparison
CRL vs RITM Comparison
Compare CRL & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- RITM
- Stock Information
- Founded
- CRL 1947
- RITM 2011
- Country
- CRL United States
- RITM United States
- Employees
- CRL N/A
- RITM N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- RITM Real Estate Investment Trusts
- Sector
- CRL Health Care
- RITM Real Estate
- Exchange
- CRL Nasdaq
- RITM Nasdaq
- Market Cap
- CRL 7.1B
- RITM 6.0B
- IPO Year
- CRL 2000
- RITM N/A
- Fundamental
- Price
- CRL $157.12
- RITM $11.76
- Analyst Decision
- CRL Hold
- RITM Strong Buy
- Analyst Count
- CRL 14
- RITM 8
- Target Price
- CRL $186.38
- RITM $13.13
- AVG Volume (30 Days)
- CRL 859.6K
- RITM 4.1M
- Earning Date
- CRL 08-06-2025
- RITM 07-30-2025
- Dividend Yield
- CRL N/A
- RITM 8.53%
- EPS Growth
- CRL N/A
- RITM N/A
- EPS
- CRL N/A
- RITM 1.19
- Revenue
- CRL $4,022,597,000.00
- RITM $3,560,550,000.00
- Revenue This Year
- CRL N/A
- RITM N/A
- Revenue Next Year
- CRL $2.49
- RITM $2.64
- P/E Ratio
- CRL N/A
- RITM $9.84
- Revenue Growth
- CRL N/A
- RITM 10.49
- 52 Week Low
- CRL $91.86
- RITM $9.13
- 52 Week High
- CRL $254.15
- RITM $12.20
- Technical
- Relative Strength Index (RSI)
- CRL 67.60
- RITM 65.43
- Support Level
- CRL $148.41
- RITM $11.14
- Resistance Level
- CRL $160.40
- RITM $11.44
- Average True Range (ATR)
- CRL 4.71
- RITM 0.17
- MACD
- CRL 0.42
- RITM 0.04
- Stochastic Oscillator
- CRL 81.08
- RITM 96.81
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.